The fallout continues from drug makers and health centers’ decision to work together to change the 340B program, with the drug industry giving its first interview about the deal to 340B Report on Friday and several hospital groups jointly blasting the initiative yesterday.
Pharmaceutical Research and Manufacturers of America and the National Association of Community Health Centers jolted 340B stakeholders on March 9 by jointly releasing a 10-point plan to guide federal 340B reform legislation. The plan says many disproportionate share hospitals are not “true” safety-net institutions and should be held to tougher 340B eligibility standards. DSH hospitals account for about 80% of 340B program sales.
The fallout continues from drug makers and health centers’ decision to work together to change the 340B program, with the drug industry giving its first interview about the deal to 340B Report on Friday and several hospital groups jointly blasting […]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
